95 related articles for article (PubMed ID: 25407497)
1. Association of the chromodomain helicase DNA-binding protein 4 (CHD4) missense variation p.D140E with cancer: potential interaction with smoking.
Yamada M; Sato N; Ikeda S; Arai T; Sawabe M; Mori S; Yamada Y; Muramatsu M; Tanaka M
Genes Chromosomes Cancer; 2015 Feb; 54(2):122-8. PubMed ID: 25407497
[TBL] [Abstract][Full Text] [Related]
2. Acetyltransferase p300 collaborates with chromodomain helicase DNA-binding protein 4 (CHD4) to facilitate DNA double-strand break repair.
Qi W; Chen H; Xiao T; Wang R; Li T; Han L; Zeng X
Mutagenesis; 2016 Mar; 31(2):193-203. PubMed ID: 26546801
[TBL] [Abstract][Full Text] [Related]
3. CHD4 variants are associated with childhood idiopathic epilepsy with sinus arrhythmia.
Liu XR; Ye TT; Zhang WJ; Guo X; Wang J; Huang SP; Xie LS; Song XW; Deng WW; Li BM; He N; Wu QY; Zhuang MZ; Xu M; Shi YW; Su T; Yi YH; Liao WP;
CNS Neurosci Ther; 2021 Oct; 27(10):1146-1156. PubMed ID: 34109749
[TBL] [Abstract][Full Text] [Related]
4. CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now.
O'Shaughnessy A; Hendrich B
Biochem Soc Trans; 2013 Jun; 41(3):777-82. PubMed ID: 23697937
[TBL] [Abstract][Full Text] [Related]
5. Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1.
Shi W; Scialdone AP; Emerson JI; Mei L; Wasson LK; Davies HA; Seidman CE; Seidman JG; Cook JG; Conlon FL
Circ Res; 2023 Jun; 133(1):48-67. PubMed ID: 37254794
[TBL] [Abstract][Full Text] [Related]
6. Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation.
Sperlazza J; Rahmani M; Beckta J; Aust M; Hawkins E; Wang SZ; Zu Zhu S; Podder S; Dumur C; Archer K; Grant S; Ginder GD
Blood; 2015 Sep; 126(12):1462-72. PubMed ID: 26265695
[TBL] [Abstract][Full Text] [Related]
7. Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4.
Guillemette S; Serra RW; Peng M; Hayes JA; Konstantinopoulos PA; Green MR; Cantor SB
Genes Dev; 2015 Mar; 29(5):489-94. PubMed ID: 25737278
[TBL] [Abstract][Full Text] [Related]
8. ¹H, ¹³C and ¹⁵N resonance assignments of an N-terminal domain of CHD4.
Silva AP; Kwan AH; Mackay JP
Biomol NMR Assign; 2014 Apr; 8(1):137-9. PubMed ID: 23417793
[TBL] [Abstract][Full Text] [Related]
9. Chromodomain helicase DNA-binding 4 (CHD4) regulates early B cell identity and V(D)J recombination.
Hagman JR; Arends T; Laborda C; Knapp JR; Harmacek L; O'Connor BP
Immunol Rev; 2022 Jan; 305(1):29-42. PubMed ID: 34927255
[TBL] [Abstract][Full Text] [Related]
10. CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer.
Chang CL; Huang CR; Chang SJ; Wu CC; Chen HH; Luo CW; Yip HK
Int J Biol Sci; 2021; 17(7):1660-1670. PubMed ID: 33994851
[TBL] [Abstract][Full Text] [Related]
11. CHD4 orchestrates the symphony of T and B lymphocytes development and a good mediator in preventing from autoimmune disease.
Jia M; Zou X; Yin S; Tian W; Zhao Y; Wang H; Xu G; Cai W; Shao Q
Immun Inflamm Dis; 2022 Jul; 10(7):e644. PubMed ID: 35759243
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel proteins associated with CHD4.
Sakaguchi C; Ichihara K; Nita A; Katayama Y; Nakayama KI
Genes Cells; 2022 Jan; 27(1):61-71. PubMed ID: 34897913
[TBL] [Abstract][Full Text] [Related]
13. Tumour-associated missense mutations in the dMi-2 ATPase alters nucleosome remodelling properties in a mutation-specific manner.
Kovač K; Sauer A; Mačinković I; Awe S; Finkernagel F; Hoffmeister H; Fuchs A; Müller R; Rathke C; Längst G; Brehm A
Nat Commun; 2018 May; 9(1):2112. PubMed ID: 29844320
[TBL] [Abstract][Full Text] [Related]
14. Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer.
Novillo A; Fernández-Santander A; Gaibar M; Galán M; Romero-Lorca A; El Abdellaoui-Soussi F; Gómez-Del Arco P
Front Oncol; 2021; 11():633233. PubMed ID: 33981601
[TBL] [Abstract][Full Text] [Related]
15. Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan.
Chang CH; Hsiao CF; Chang GC; Tsai YH; Chen YM; Huang MS; Su WC; Hsieh WS; Yang PC; Chen CJ; Hsiung CA
Am J Epidemiol; 2009 Sep; 170(6):695-702. PubMed ID: 19671832
[TBL] [Abstract][Full Text] [Related]
16. The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer.
Wang J; Zhong F; Li J; Yue H; Li W; Lu X
J Transl Med; 2023 Jan; 21(1):38. PubMed ID: 36681835
[TBL] [Abstract][Full Text] [Related]
17. Dermatomyositis autoantigen CHD4 forms immune stimulatory complexes with endogenous DNA.
Guel T; Scholtissek B; Siegl J; Fetter T; Mayer G; Bieber T; Wenzel J
Exp Dermatol; 2023 Jul; 32(7):965-974. PubMed ID: 36995066
[TBL] [Abstract][Full Text] [Related]
18. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk.
Ito H; Matsuo K; Hamajima N; Mitsudomi T; Sugiura T; Saito T; Yasue T; Lee KM; Kang D; Yoo KY; Sato S; Ueda R; Tajima K
Carcinogenesis; 2004 Aug; 25(8):1395-401. PubMed ID: 15044328
[TBL] [Abstract][Full Text] [Related]
19. Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer.
Hu Z; Huo X; Lu D; Qian J; Zhou J; Chen Y; Xu L; Ma H; Zhu J; Wei Q; Shen H
Clin Cancer Res; 2005 Aug; 11(15):5433-9. PubMed ID: 16061858
[TBL] [Abstract][Full Text] [Related]
20. β1 integrin signaling governs necroptosis via the chromatin-remodeling factor CHD4.
Sun Z; Cernilogar FM; Horvatic H; Yeroslaviz A; Abdullah Z; Schotta G; Hornung V
Cell Rep; 2023 Nov; 42(11):113322. PubMed ID: 37883227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
